Last reviewed · How we verify

NCT05153421: CBC035M

Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.

Terminated NA Last updated 28 January 2025
What this trial tests

NA trial testing All'InCath CBC 035M Balloon Dilatation Catheter in Vascular Diseases in 30 participants. Terminated before completion.

Timeline
6 May 2021
Primary endpoint
6 December 2024
6 December 2024

Quick facts

Lead sponsorNexStep Medical
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date6 May 2021
Primary completion6 December 2024
Estimated completion6 December 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

NexStep Medical

Who can join

18 and older, any sex, with Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the clinical safety, performance and benefits (e.g. decrease of procedure time, decrease of radiation time, decrease of the amount of injected contrast, delivery and ease of use) of a novel balloon catheter that combines angiography and angioplasty capabilities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of All'InCath CBC 035M Balloon Dilatation Catheter

Trials testing the same drug.

Other recruiting trials for Vascular Diseases

Currently open trials in the same condition.

Other NexStep Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05153421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing